S
Sera Economics
← US Companies

Moderna, Inc.

MRNA · Nasdaq · CIK 0001682852

SIC 2836

Biological Products, (No Diagnostic Substances)

Category

Chemicals

Entity

operating

Incorp.

DE

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Investment Indicators

ROE

-32.62%

ROA

-22.87%

D/E Ratio

0.43

Current Ratio

3.29

Operating Margin

-15.96%

Net Margin

-14.65%

Book Value/Share

$21.95

Financial Statements

In USD millions (per-share figures shown directly) · Financials as of: 2026-02-20

Income Statement

FY20252024202320222021
Revenue19,26318,471
Cost of Revenue8681,4644,6935,4162,617
Operating Income-3,074-3,945-4,2399,42013,296
Net Income-2,822-3,561-4,7148,36212,202
EPS (Basic)-7.26-9.28-12.3321.2630.31
EPS (Diluted)-7.26-9.28-12.3320.1228.29

Balance Sheet

FY20252024202320222021
Total Assets12,33814,14218,42625,85824,669
Current Assets6,5448,09910,32513,43116,071
Cash & Equivalents2,5951,9272,9073,2056,848
Total Liabilities3,6883,2414,5726,73510,524
Current Liabilities1,9872,2063,0154,9239,128
Long-term Debt590
Total Equity8,65010,90113,85419,12314,145

Cash Flow

FY20252024202320222021
Operating CF-1,873-3,004-3,1184,98113,620
Investing CF1,9461,9494,206-5,176-8,523
Financing CF59356-1,377-3,448-873
CapEx1921,051707400284

📄 SEC Filings

Other filings (81)
4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-08

Open →

144

144

xsl144X01/primary_doc.xml

2026-05-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-05-04

Open →

144

144

xsl144X01/primary_doc.xml

2026-05-01

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-30

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-04-06

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-03-27

Open →

DEFA14A

DEFA14A

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

2026-03-16

Open →

ARS

ARS

ANNUAL REPORT TO SECURITY HOLDERS

2026-03-16

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-03-03

Open →

144

144

xsl144X01/primary_doc.xml

2026-03-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-25

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-23

Open →

S-8

S-8

S-8

2026-02-20

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-13

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-13

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-13

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-02-13

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2026-02-09

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2026-02-06

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X01/primary_doc.xml

2026-02-05

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2026-01-06

Open →

SC TO-I/A

SC TO-I/A

SC TO-I/A

2025-12-16

Open →

4

Insider Transaction

4

2025-12-15

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-15

Open →

144

144

xsl144X01/primary_doc.xml

2025-12-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-11

Open →

144

144

xsl144X01/primary_doc.xml

2025-12-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-08

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-01

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-01

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-12-01

Open →

SC TO-I/A

SC TO-I/A

SC TO-I/A

2025-11-18

Open →

SC TO-I

SC TO-I

SC TO-I

2025-11-13

Open →

SC TO-C

SC TO-C

SC TO-C

2025-11-12

Open →

SC TO-C

SC TO-C

SC TO-C

2025-11-06

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X01/primary_doc.xml

2025-11-05

Open →

SC TO-C

SC TO-C

SC TO-C

2025-10-21

Open →

DEFA14A

DEFA14A

DEFA14A

2025-10-20

Open →

SC TO-C

SC TO-C

SC TO-C

2025-10-10

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-10-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-10-06

Open →

SC TO-C

SC TO-C

SC TO-C

2025-10-03

Open →

PRE 14A

PRE 14A

OTHER PRELIMINARY PROXY STATEMENTS

2025-10-03

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-09-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-09-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-08-29

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-08-29

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-08-29

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-08-06

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-07-07

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-12

Open →

144

144

xsl144X01/primary_doc.xml

2025-06-11

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-09

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-06-02

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-29

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-29

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-29

Open →

SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X01/primary_doc.xml

2025-05-12

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-01

Open →

4

Insider Transaction

PRIMARY DOCUMENT

2025-05-01

Open →

Moderna, Inc. (MRNA) — Biological Products, (No Diagnostic Substances) | Sera Economics